Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.
Philips Healthcare has acquired Xhale Assurance Inc. to add a novel pulse oximetry technology to complement its patient monitoring portfolio, which already offers the marketing-leading Rainbow SET pulse oximetry products from Masimo Corp.
Philips announced Aug. 29 that it bought Florida-based Xhale, developer of the SpO2 sensor, for an undisclosed sum. Xhale was...
SetPoint Medical secured US FDA approval for its vagus nerve neuromodulation device to treat RA. Now, the start-up is tasked with convincing both rheumatologist and surgeons to adopt its technology over or alongside biologic drugs. CEO Murthy Simhambhatla talks exit strategy plans.
IQWiG, Germany’s health technology assessment body, is making contingency plans in case key US resources it relies on for information retrieval, when conducting benefit assessments of new medicines, become unavailable.
The vision company expects total annual revenues of $10.3bn-$10.4bn, marking a slower growth rate than earlier forecasts. However, management remains optimistic that overall trends, as well as recent purchases like STAAR and LumiThera, represent a significant market opportunity.
